Evidence map›Paper›PMID 26377725›Full record

ReviewCardiology in the young2015

Paediatric cardiovascular clinical trials: an analysis of ClinicalTrials.gov and the Food and Drug Administration Pediatric Drug Labeling Database.

Kevin D Hill, Heather T Henderson, Christoph P Hornik, Jennifer S Li

Abstract readReview
In one paragraph

Review in Cardiology in the young, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Postnatal Development Shapes the Cardiac Response to Milrinone.bioRxiv : the preprint server for biology · 2026
    Article
  3. Impact of COVID-19 disease on clinical research in pediatric and congenital cardiology.Archives de pediatrie : organe officiel de la Societe francaise de pediatrie · 2022
    Observational
  4. Article
  5. Article
  6. Article
  7. Pediatric cardiology: In search for evidence.Annals of pediatric cardiology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kevin D Hill1Duke University Medical Center,Durham,North Carolina,United States of America.
Heather T Henderson1Duke University Medical Center,Durham,North Carolina,United States of America.
Christoph P Hornik1Duke University Medical Center,Durham,North Carolina,United States of America.
Jennifer S Li1Duke University Medical Center,Durham,North Carolina,United States of America.

Funding

Duke CTSA (Composite)UL1TR001117 · NCATS · DUKE UNIVERSITY · PI BOULWARE, LEIGH E, LI, JENNIFER S · 2013 to 2017
$41.3M
Duke CTSA (Composite)KL2TR001115 · NCATS · DUKE UNIVERSITY · PI BOULWARE, LEIGH E, KRAFT, MONICA · 2013 to 2017
$5.1M
FDA HHS U01 FD004858NCATS NIH HHS KL2 TR001115NCATS NIH HHS KL2TR001115-02NCATS NIH HHS UL1 TR001117NCATS NIH HHS UL1TR001117NHLBI NIH HHS L40 HL129245
6 · The paper itself

Abstract

Recent regulatory initiatives in the United States of America and Europe have transformed the paediatric clinical trials landscape by significantly increasing capital investment and paediatric trial volume. The purpose of this manuscript was to review the impact of these initiatives on the paediatric cardiovascular trials landscape when compared with other paediatric sub-specialties. We also evaluate factors that may have contributed to the success or failure of recent major paediatric cardiovascular trials so as to inform the optimal design and conduct of future trials in the field.

Indexed as

PediatricsCardiovascular DiseasesClinical Trials as TopicDatabases, FactualDrug LabelingEuropeHumansUnited StatesUnited States Food and Drug Administrationheart failurePediatric cardiovascular trialspediatric exclusivity

Identifiers

PMID26377725
PMCPMC4591024

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.